Switch to:
More From Other Websites
Specialty Pharma: Earnings Better Be Good…or Else Jul 25 2016
Most Popular Canadian Stocks Among Hedge Funds Jul 25 2016
Ackman's Bad Bets Costs $600 Million in Redemptions Jul 24 2016
2:32 am Valeant Pharma receives Complete Response Letter from the FDA regarding the New Drug... Jul 24 2016
[$$] Valeant: Not All Delays Are Created Equal Jul 22 2016
[$$] Overheard Jul 22 2016
CANADA STOCKS-TSX at highest close in year, 4th weekly gain; telecoms shine Jul 22 2016
‘Deficiencies’ at Bausch + Lomb manufacturing plant in Tampa put glaucoma drug on hold Jul 22 2016
Valeant Hits Another Bump Jul 22 2016
Valeant Slides as FDA Report Hampers Drug Application Jul 22 2016
Valeant just got blindsided Jul 22 2016
Valeant’s latest woe isn’t even financial Jul 22 2016
Valeant Pharmaceuticals: It Had to End Some Time Jul 22 2016
Valeant: Not All Delays Are Created Equal Jul 22 2016
Valeant (VRX) Stock Down on Concerns About Glaucoma Treatment Jul 22 2016
Morning Movers: General Electric Falls on Earnings; Valeant Drops Jul 22 2016
Valeant Drug Approval Hampered by FDA Facility Inspection Jul 22 2016
U.S. FDA raises concerns over Valeant's eye drop Jul 22 2016
Valeant Pharmaceuticals Receives Complete Response Letter From The FDA Jul 22 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK